Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation

BACKGROUND: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) followed by upfront autologous st...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Res
Главные авторы: Lee, Hong Ghi, Kim, Sung-Yong, Kim, Inho, Kim, Yeo-Kyeoung, Kim, Jeong-A, Kim, Yang Soo, Lee, Ho Sup, Park, Jinny, Kim, Seok Jin, Shim, Hyeok, Eom, Hyeon Seok, Park, Byeong-Bae, Lee, Junglim, Park, Sung Kyu, Cheong, June-Won, Park, Keon Woo
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595582/
https://ncbi.nlm.nih.gov/pubmed/26457283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.3.160
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы